Concepedia

Akiko Kurimoto

AK

6

Publications

396

Citations

6

H-Index

2015

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

The University of Tokyo

RIKEN Center for Integrative Medical Sciences

Akiko Kurimoto is an author at Daiichi-Sankyo (Japan) specializing in cell biology, medicine, and colorectal cancer.

Top concepts

Publications per year

2015–2023

6

Publications

6

Long noncoding RNA <i>UPAT</i> promotes colon tumorigenesis by inhibiting degradation of UHRF1

Kenzui Taniue, Akiko Kurimoto, Hironobu Sugimasa et al. · Proceedings of the National Academy of Sciences · 2016 · 158 citations · Full text

<i>ASBEL</i> –TCF3 complex is required for the tumorigenicity of colorectal cancer cells

Kenzui Taniue, Akiko Kurimoto, Yasuko Takeda et al. · Proceedings of the National Academy of Sciences · 2016 · 81 citations · Full text

UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells

Kenzui Taniue, Tomoatsu Hayashi, Yuki Kamoshida et al. · Oncogene · 2019 · 68 citations

, , +11

Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells

Hironobu Sugimasa, Kenzui Taniue, Akiko Kurimoto et al. · Biochemical and Biophysical Research Communications · 2015 · 44 citations

, , +8

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1

Masashi Numata, Noriyasu Haginoya, Machiko Shiroishi et al. · Cancer Cell International · 2023 · 26 citations · Full text

Rows per page

1–5 of 6